Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015 (2015), Article ID 476041, 6 pages
http://dx.doi.org/10.1155/2015/476041
Review Article

Gastrointestinal Biopsies for the Diagnosis of Alpha-Synuclein Pathology in Parkinson’s Disease

Parkinson Disease and Movement Disorders Unit, Hospital de Clínicas, University of Buenos Aires, GCBA, C1120AAR Buenos Aires, Argentina

Received 3 December 2014; Accepted 28 April 2015

Academic Editor: Paul Enck

Copyright © 2015 Maria Graciela Cersosimo. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Fahn, “Parkinson's disease: 10 years of progress, 1997–2007,” Movement Disorders, vol. 25, supplement 1, pp. S2–S14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. K. R. Chaudhuri, D. G. Healy, and A. H. V. Schapira, “Non-motor symptoms of Parkinson's disease: diagnosis and management,” The Lancet Neurology, vol. 5, no. 3, pp. 235–245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. L. L. Edwards, E. M. M. Quigley, and R. F. Pfeiffer, “Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology,” Neurology, vol. 42, no. 4, pp. 726–732, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. M. G. Cersosimo, G. B. Raina, C. Pecci et al., “Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms,” Journal of Neurology, vol. 260, no. 5, pp. 1332–1338, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. W. R. G. Gibb and A. J. Lees, “The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease,” Journal of Neurology Neurosurgery and Psychiatry, vol. 51, no. 6, pp. 745–752, 1988. View at Publisher · View at Google Scholar · View at Scopus
  6. M. G. Spillantini, M. L. Schmidt, V. M.-Y. Lee, J. Q. Trojanowski, R. Jakes, and M. Goedert, “α-Synuclein in Lewy bodies,” Nature, vol. 388, no. 6645, pp. 839–840, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. M. G. Spillantini, R. A. Crowther, R. Jakes, M. Hasegawa, and M. Goedert, “α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 11, pp. 6469–6473, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. T. G. Beach, C. H. Adler, L. I. Sue et al., “Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders,” Acta Neuropathologica, vol. 119, no. 6, pp. 689–702, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Fumimura, M. Ikemura, Y. Saito et al., “Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease,” Journal of Neuropathology and Experimental Neurology, vol. 66, no. 5, pp. 354–362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Wakabayashi, F. Mori, K. Tanji, S. Orimo, and H. Takahashi, “Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain,” Acta Neuropathologica, vol. 120, no. 1, pp. 1–12, 2010. View at Publisher · View at Google Scholar
  11. K. Del Tredici, C. H. Hawkes, E. Ghebremedhin, and H. Braak, “Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease,” Acta Neuropathologica, vol. 119, no. 6, pp. 703–713, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Lebouvier, T. Chaumette, P. Damier et al., “Pathological lesions in colonic biopsies during Parkinson's disease,” Gut, vol. 57, no. 12, pp. 1741–1743, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. G. Cersosimo, C. Perandones, F. E. Micheli et al., “Alpha-synuclein immunoreactivity in minor salivary gland biopsies of Parkinson's disease patients,” Movement Disorders, vol. 26, no. 1, pp. 188–190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. K. M. Shannon, A. Keshavarzian, E. Mutlu et al., “Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease,” Movement Disorders, vol. 27, no. 6, pp. 709–715, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. C. H. Adler, B. N. Dugger, M. L. Hinni et al., “Submandibular gland needle biopsy for the diagnosis of Parkinson disease,” Neurology, vol. 82, no. 10, pp. 858–864, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. H. McCann, C. H. Stevens, H. Cartwright, and G. M. Halliday, “α-synucleinopathy phenotypes,” Parkinsonism and Related Disorders, vol. 20, supplement 1, pp. S62–S67, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Asahina, E. Vichayanrat, D. A. Low, V. Iodice, and C. J. Mathias, “Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 84, no. 6, pp. 674–680, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. J. Qualman, H. M. Haupt, P. Yang, and S. R. Hamilton, “Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease,” Gastroenterology, vol. 87, no. 4, pp. 848–856, 1984. View at Google Scholar · View at Scopus
  19. K. Wakabayashi, H. Takahashi, S. Takeda, E. Ohama, and F. Ikuta, “Parkinson's disease: the presence of lewy bodies in Auerbach's and Meissner's plexuses,” Acta Neuropathologica, vol. 76, no. 3, pp. 217–221, 1988. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Wakabayashi, H. Takahashi, E. Ohama, and F. Ikuta, “Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system,” Acta Neuropathologica, vol. 79, no. 6, pp. 581–583, 1990. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Braak, R. A. I. de Vos, J. Bohl, and K. Del Tredici, “Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology,” Neuroscience Letters, vol. 396, no. 1, pp. 67–72, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Christensen, M. J. Stiles, G. A. Rick, and J. Sutherland, “Comparative anatomy of the myenteric plexus of the distal colon in eight mammals,” Gastroenterology, vol. 86, no. 4, pp. 706–713, 1984. View at Google Scholar · View at Scopus
  23. M. Ikemura, Y. Saito, R. Sengoku et al., “Lewy body pathology involves cutaneous nerves,” Journal of Neuropathology and Experimental Neurology, vol. 67, no. 10, pp. 945–953, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. D. A. Hopkins, D. Bieger, J. de Vente, and H. W. M. Steinbusch, “Vagal efferent projections: viscerotopy, neurochemistry and effects of vagotomy,” Progress in Brain Research, vol. 107, pp. 79–96, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Braak, U. Rüb, W. P. Gai, and K. Del Tredici, “Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen,” Journal of Neural Transmission, vol. 110, no. 5, pp. 517–536, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Braak, K. Del Tredici, H. Bratzke, J. Hamm-Clement, D. Sandmann-Keil, and U. Rüb, “Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages),” Journal of Neurology, vol. 249, no. 3, pp. 1–5, 2002. View at Google Scholar · View at Scopus
  27. H. Braak, K. Del Tredici, U. Rüb, R. A. I. De Vos, E. N. H. Jansen Steur, and E. Braak, “Staging of brain pathology related to sporadic Parkinson's disease,” Neurobiology of Aging, vol. 24, no. 2, pp. 197–211, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Braak, E. Ghebremedhin, U. Rüb, H. Bratzke, and K. Del Tredici, “Stages in the development of Parkinson's disease-related pathology,” Cell and Tissue Research, vol. 318, no. 1, pp. 121–134, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. D. W. Dickson, H. Fujishiro, A. DelleDonne et al., “Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease,” Acta Neuropathologica, vol. 115, no. 4, pp. 437–444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. A. E. Kingsbury, R. Bandopadhyay, L. Silveira-Moriyama et al., “Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model,” Movement Disorders, vol. 25, no. 15, pp. 2508–2515, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. M. E. Kalaitzakis, M. B. Graeber, S. M. Gentleman, and R. K. B. Pearce, “The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of α-synuclein staging,” Neuropathology and Applied Neurobiology, vol. 34, no. 3, pp. 284–295, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. J.-Y. Li, E. Englund, J. L. Holton et al., “Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation,” Nature Medicine, vol. 14, no. 5, pp. 501–503, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. J. H. Kordower, Y. Chu, R. A. Hauser, T. B. Freeman, and C. W. Olanow, “Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease,” Nature Medicine, vol. 14, no. 5, pp. 504–506, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Recasens, B. Dehay, J. Bové et al., “Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys,” Annals of Neurology, vol. 75, no. 3, pp. 351–362, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. K. C. Luk, V. Kehm, J. Carroll et al., “Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice,” Science, vol. 338, no. 6109, pp. 949–953, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Goedert, B. Falcon, F. Clavaguera, and M. Tolnay, “Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies,” Current Neurology and Neuroscience Reports, vol. 14, no. 11, article 495, 2014. View at Publisher · View at Google Scholar
  37. M. Beekes, A. Thomzig, W. J. Schulz-Schaeffer, and R. Burger, “Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles?” Acta Neuropathologica, vol. 128, no. 4, pp. 463–476, 2014. View at Publisher · View at Google Scholar
  38. M. G. Cersosimo, “Invasive procedures in Parkinson's disease: let's be aware we are dealing with prion-like proteins,” Journal of the Neurological Sciences, vol. 351, no. 1-2, pp. 200–201, 2015. View at Publisher · View at Google Scholar
  39. T. Lebouvier, M. Neunlist, S. Bruley des Varannes et al., “Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms,” PloS ONE, vol. 5, no. 9, Article ID e12728, 2010. View at Google Scholar · View at Scopus
  40. A. Sánchez-Ferro, A. Rábano, M. J. Catalán et al., “In vivo gastric detection of α-synuclein inclusions in Parkinson's disease,” Movement Disorders, vol. 30, no. 4, pp. 517–524, 2015. View at Publisher · View at Google Scholar
  41. E. Folgoas, T. Lebouvier, L. Leclair-Visonneau et al., “Diagnostic value of minor salivary glands biopsy for the detection of Lewy pathology,” Neuroscience Letters, vol. 551, pp. 62–64, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Pouclet, T. Lebouvier, E. Coron, M. Neunlist, and P. Derkinderen, “Lewy pathology in gastric and duodenal biopsies in Parkinson's Disease,” Movement Disorders, vol. 27, no. 6, p. 708, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. K. M. Shannon, A. Keshavarzian, H. B. Dodiya, S. Jakate, and J. H. Kordower, “Is alpha-synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases,” Movement Disorders, vol. 27, no. 6, pp. 716–719, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Pouclet, T. Lebouvier, E. Coron et al., “A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease,” Neurobiology of Disease, vol. 45, no. 1, pp. 305–309, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Pouclet, T. Lebouvier, E. Coron, S. B. Des Varannes, M. Neunlist, and P. Derkinderen, “A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson's disease,” Neurogastroenterology and Motility, vol. 24, no. 4, pp. e202–e205, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Minguez-Castellanos, C. E. Chamorro, F. Escamilla-Sevilla et al., “Do α-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study,” Neurology, vol. 68, no. 23, pp. 2012–2018, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Ito, M. Takao, H. Hatsuta et al., “Alpha-synuclein immunohistochemistry of gastrointestinal and biliary surgical specimens for diagnosis of Lewy body disease,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 4, pp. 1714–1723, 2014. View at Google Scholar · View at Scopus